Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,280 | 10,900 | 6,840 | 8,160 | 14,940 |
| Receivables | 98,100 | 81,530 | 76,200 | 84,280 | 70,210 |
| Inventories | 25,340 | 28,470 | 22,890 | 18,860 | 15,890 |
| Other current assets | 14,910 | 16,050 | 16,890 | 15,140 | 9,010 |
| TOTAL | $155,630 | $136,950 | $122,820 | $126,440 | $110,050 |
| Non-Current Assets | |||||
| PPE Net | 86,830 | 88,740 | 90,050 | N/A | 80,990 |
| Investments And Advances | 0 | 0 | 0 | 0 | 1,190 |
| Other Non-Current Assets | 156,580 | 152,070 | 153,250 | 153,960 | 158,380 |
| TOTAL | $243,410 | $240,810 | $243,300 | $153,960 | $240,560 |
| Total Assets | $375,750 | $354,760 | $344,790 | $348,600 | $327,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,370 | 18,420 | 22,870 | 18,350 | 9,420 |
| Accounts payable and accrued liabilities | 15,750 | 14,580 | 16,700 | 18,520 | 13,890 |
| Accrued Expenses | 0 | 0 | 0 | 17,550 | 25,590 |
| Other current liabilities | 28,780 | 21,180 | 22,820 | 430 | 170 |
| TOTAL | $45,910 | $54,190 | $62,400 | $61,220 | $49,280 |
| Non-Current Liabilities | |||||
| Long Term Debt | 104,270 | 83,310 | 68,050 | 68,230 | 73,360 |
| Other Non-Current Liabilities | 21,150 | 22,440 | 22,390 | 16,470 | 15,700 |
| TOTAL | $126,450 | $105,840 | $90,580 | $90,390 | $89,060 |
| Total Liabilities | $172,380 | $160,040 | $153,000 | $151,640 | $138,350 |
| Shareholders' Equity | |||||
| Common Shares | 500 | 490 | 490 | 490 | 480 |
| Retained earnings | 42,880 | 40,960 | 38,080 | 44,290 | 41,370 |
| Other shareholders' equity | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $203,370 | $194,710 | $191,790 | $196,960 | $189,000 |
| Total Liabilities And Equity | $375,750 | $354,750 | $344,790 | $348,600 | $327,350 |